FBN Securities Begins Coverage on Docusign (NASDAQ:DOCU)

Share on StockTwits

FBN Securities initiated coverage on shares of Docusign (NASDAQ:DOCU) in a research report report published on Tuesday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $60.00 price target on the stock.

Other equities analysts have also issued reports about the stock. ValuEngine upgraded shares of Zogenix from a buy rating to a strong-buy rating in a research report on Thursday, June 27th. William Blair reiterated an outperform rating on shares of Vail Resorts in a research report on Friday, June 7th. Piper Jaffray Companies reduced their target price on shares of Zafgen from $18.00 to $6.00 and set a hold rating on the stock in a research report on Monday, March 11th. Finally, Wedbush set a $17.00 target price on shares of Zumiez and gave the stock a sell rating in a research report on Friday, June 7th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $61.36.

Shares of DOCU stock opened at $53.80 on Tuesday. Docusign has a 1 year low of $35.06 and a 1 year high of $68.35. The business’s 50 day moving average is $51.95. The firm has a market capitalization of $8.92 billion, a price-to-earnings ratio of -18.55 and a beta of 1.30. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.76 and a quick ratio of 1.76.

Docusign (NASDAQ:DOCU) last announced its earnings results on Thursday, June 6th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.23) by $0.30. Docusign had a negative net margin of 26.54% and a negative return on equity of 22.27%. The company had revenue of $213.96 million for the quarter, compared to analyst estimates of $208.15 million. During the same period in the prior year, the business earned $0.01 earnings per share. Docusign’s quarterly revenue was up 37.3% on a year-over-year basis. Equities research analysts anticipate that Docusign will post -0.99 earnings per share for the current year.

In related news, COO Scott V. Olrich sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $54.85, for a total transaction of $548,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Peter Solvik sold 541,532 shares of the business’s stock in a transaction that occurred on Tuesday, July 9th. The stock was sold at an average price of $51.52, for a total transaction of $27,899,728.64. The disclosure for this sale can be found here. Over the last three months, insiders have sold 600,988 shares of company stock valued at $31,067,181. 13.60% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Sonora Investment Management LLC bought a new stake in shares of Docusign during the first quarter worth approximately $31,000. Clean Yield Group bought a new stake in shares of Docusign during the first quarter worth approximately $31,000. Legacy Advisors LLC bought a new stake in shares of Docusign during the first quarter worth approximately $38,000. Rehmann Capital Advisory Group raised its stake in shares of Docusign by 226.1% during the first quarter. Rehmann Capital Advisory Group now owns 874 shares of the company’s stock worth $45,000 after buying an additional 606 shares during the last quarter. Finally, Shine Investment Advisory Services Inc. bought a new stake in shares of Docusign during the first quarter worth approximately $66,000. 61.15% of the stock is owned by institutional investors and hedge funds.

About Docusign

DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.

Featured Story: What does a neutral rating on stocks mean?

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Increases AvalonBay Communities  Price Target to $224.00
JPMorgan Chase & Co. Increases AvalonBay Communities Price Target to $224.00
Brightsphere Investment Group  Lifted to “Hold” at Zacks Investment Research
Brightsphere Investment Group Lifted to “Hold” at Zacks Investment Research
PLDT  Rating Lowered to Hold at Zacks Investment Research
PLDT Rating Lowered to Hold at Zacks Investment Research
AtriCure  Stock Rating Lowered by Northland Securities
AtriCure Stock Rating Lowered by Northland Securities
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Meridian Bioscience  Rating Lowered to Sell at ValuEngine
Meridian Bioscience Rating Lowered to Sell at ValuEngine


 
© 2006-2019 Zolmax.